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access article under the CC BY-NC-NDSummary Background/Objective: Asporin is associated with osteoarthritis and lumbar disk
degeneration. Previous studies in chondrocytes showed that asporin can bind to transforming
growth factor-b1 (TGF-b1) and downregulate matrix biosynthesis. However, this has not been
studied in intervertebral disk (IVD) cells. This study aimed to inspect the expression of asporin
under TGF-b1 stimulation and its effect on TGF-b1-induced matrix biosynthesis in human inter-
vertebral annulus cells.
Methods: Human intervertebral annulus cells were obtained from the pathological region of
IVD in eight patients. After primary culture and redifferentiation in alginate beads, cells were
reseeded and treated with different concentrations (5 ng/mL, 10 ng/mL, and 15 ng/mL) of
TGF-b1 for up to 24 hours. Total RNA extracted from the cells and those with asporin knock-
down were subjected to real-time polymerase chain reaction analysis to examine the expres-
sion of asporin and extracellular matrix genes.
Results: TGF-b1 stimulation induces asporin transcription significantly in a dose- and time-
dependent manner. Knockdown of endogenous asporin leads to the upregulated expression
of collagen II alpha 1 and aggrecan.
Conclusion: Our results have verified a functional feedback loop between TGF-b1 and asporin
in human intervertebral annulus cells indicating that TGF-b1-induced annulus matrix biosyn-
thesis can be significantly upregulated by knockdown of asporin. Therefore, asporin could
be a potential new therapeutic target and inhibition of asporin could be adopted to enhanceof Orthopaedics, Beijing Jishuitan Hospital, 4th Clinical Medical College of Peking University, Beijing
om (W. Tian).
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Degenerative disk disease (DDD) is the most prevalent dis-
ease affecting the human spine, and represents a leading
cause of low back pain in aging populations [1]. DDD is
characterised by the destruction of the normal tissue
structure from an imbalance between catabolism and
anabolism. Physiologically, the disk cells actively regulate
the homeostasis of intervertebral disk tissue under normal
conditions. These cells maintain a balance between anab-
olism and catabolism by modulating their activity [2].
However, the underlying molecular mechanism is not
clearly elucidated. Several noncollagenous extracellular
matrix (ECM) components may contribute to the degener-
ative process of DDD, and among them is asporin [3].
Asporin is a member of the class I small leucine-rich proteo-
glycan (SLRP) protein family, which has been found to be
expressed in the ECM of osteoarthritic cartilage [4], degen-
erated intervertebral disk (IVD) [3], and pathological skin scars
[5,6]. The name of asporin is derived from the combination of
aspartate (asp-) anddecorin (-orin),dueto theuniquestretchof
aspartate residues (D-repeat) at its N-terminus and the overall
similarities with decorin [7]. Polymorphisms were identified in
the D-repeat domain, and a significant association was found
between D14 allele and osteoarthritis in Chinese and Japanese
populations [4,8,9]. Recent studies showed that theD14allele is
also significantly associated with lumbar disk degeneration in
Asian individuals [3]. Moreover, asporin is mainly found in the
outer annulus cells, and its increased expression is associated
with the level of disk degeneration [10].
An in vitro study showed that, like several other SLRP
members, transforming growth factor-b1 (TGF-b1) upregu-
lated the expression of asporin [11], but asporin itself forms
a functional feedback loop through binding directly to TGF-
b1, thereby preventing the interaction of TGF-b1 with its
in vivo type II receptor, and the TGF-b1-induced expression
of cartilage matrix genes and chondrogenesis [12]. How-
ever, the results from chondrogenic cell models have not
been verified in human IVD cells.
In this study, we examined the expression of asporin
under TGF-b1 stimulation in cultured human intervertebral
annulus cells and inspected the effect of the knocking down
of asporin on the expression of aggrecan (ACAN ) and
collagen II alpha 1 (COL2A1).
Materials and methods
Isolation and primary culture of human
intervertebral annulus cells
The experimental study of human disk specimens was
approved and supervised by the Human SubjectsInstitutional Ethical Review Board at the Beijing Jishuitan
Hospital, Beijing, China. All patients signed the informed
consent form for the use of their disk specimens in
research, and the confidentiality of all patients’ personal
information was carefully maintained. Annulus specimens
from the pathological region of IVD were derived from a
routine disk procedure performed on eight patients (aged
11e28 years; 2 women and 6 men) with lumbar disk her-
niation. After careful debridement and washing, the
specimens were minced and incubated at 37C in 0.25%
trypsin (Sigma-Aldrich Corporation, Lenexa, KS, USA) for 2
hours followed by 0.2% collagenase II (Sigma-Aldrich Cor-
poration) overnight digestion until the ECM was
completely dissolved. Cells were harvested per plate at a
density of 1  105 cells/mL in Dulbecco’s modified eagle
medium (DMEM)/F12 1:1 (Gibco-BRL Life Technologies,
Grand Island, NY, USA) supplemented with 10% foetal
bovine serum, 1% (volume/volume) penicillin and strep-
tomycin (Sigma-Aldrich Corporation) at 37C, 5% carbon
dioxide, and 90% atmospheric humidity.
Three-dimensional culture of human intervertebral
annulus cells in alginate beads
Monolayer cultured human annulus cells were collected
and resuspended at a concentration of
approximately 4  105 cells/mL in a 1.2% low-viscosity
alginate sodium solution (Sigma-Aldrich Corporation).
The alginate suspension was added in 102mM CaCl2
dropwise through a 22-gauge needle. The beads were
polymerised in the CaCl2 solution and then washed twice
with 0.15M NaCl. Then, the beads were resuspended
(7e15 beads/mL) in DMEM/F12 growth medium. The
medium was changed every 3 days for 2 weeks. At the
end of the culture period, the beads were depoly-
merised by adding three volumes of 55mM sodium cit-
rate/0.15M NaCl, pH 6, and incubated at 37C for 10
minutes. The cell pellets were centrifuged (300g),
washed twice with phosphate-buffered saline, reseeded,
and cultured in a six-well plate at a density of
1  105 cells/well in the DMEM/F12 growth medium until
they reached confluence.
Induction of asporin by TGF-b1
When the cells cultured in the six-well plate reached
confluence, the culture medium was replaced with DMEM/
F12 containing 0.2% foetal bovine serum. After 12 hours,
the cells were treated with different concentrations of
TGF-b1 (Sigma-Aldrich Corporation; 5 ng/mL, 10 ng/mL,
and 15 ng/mL) and examined at different time points (6
hours, 12 hours, 18 hours, and 24 hours).
Roles of asporin in intervertebral annulus cells 3RNA isolation and real-time polymerase chain
reaction assays
The induction of asporin, ACAN, and COL2A1 by TGF-b1 was
examined. The total RNA from cultured cells was extracted
using Trizol reagent (Invitrogen Life Technologies, Carls-
bad, CA, USA) and reverse transcribed into cDNA using the
ImProm-II Transcription System (Promega Corporation,
Madison, WI, USA). Quantitative real-time polymerase
chain reaction (PCR) was performed using the SYBR Green
method. Gene-specific primers were designed using the
Primer Express 2 software (Applied BioSystems, Foster City,
CA, USA; Table 1). The reactions were conducted on an ABI
PRISM 7300 system (Applied Biosystems) using the Power
SYBR Green PCR kit (Applied Biosystems) according to the
manufacturers’ instructions. Two microlitres of each
reverse transcription reaction mixture was used as a tem-
plate for the real-time PCR. PCR cycling conditions were set
as follows: 94C for 15 minutes, followed by 40 cycles at
94C, 55C, and 72C for 30 seconds. The 2-DCt and 2-DDCt
methods were used to calculate the relative expression of
each target gene, and the values were normalized to
glyceraldehyde-3-phosphate dehydrogenase levels.
Knockdown of asporin by small interfering RNA
Predesigned small interfering RNA (siRNA) was purchased
from Invitrogen Life Technologies with targeting sequences
of 50-AAGUGAAGCUCCAAUAAAGUUGGUG-30 and 50-CACCAA-
CUUUAUUGGAGCUUCACUU-30. As a negative control, a
scrambled siRNA with similar guanineecytosine content
(Invitrogen Life Technologies) was transfected under the
same conditions. The siRNAs were transfected into cultured
human annulus cells using Entranster-R transfection reagent
(Engreen Biosystem Corporation Limited, Beijing, China),
and the transfection system was optimised according to the
manufacturers’ instructions. Twenty-four hours after trans-
fection, cells were treated with TGF-b1 (10 ng/mL) for 24
hours, and subjected to real-time PCR analysis.
Western blot analysis
Western blot analysis was performed as described previously
[13]. Equal protein samples of 50 mg from the cell lysate
were subjected to sodium dodecyl sulfate polyacrylamide
gel electrophoresis and transferred onto polyvinylideneTable 1 Primers for real-time polymerase chain reaction.
Primers Sequences (50 to 30)
Asporin F CTGGGCCTAGGAAACAACAA
Asporin R TTCATCTTTGGCACTGTTGG
Aggrecan F TCTACCGCTGCGAGGTGAT
Aggrecan R TGTAATGGAACACGATGCCTTT
Collagen II alpha 1 F GGAAGAGTGGAGACTACTGGATTGAC
Collagen II alpha 1 R TCCATGTTGCAGAAAACCTTCA
GAPDH F ACCACAGTCCATGCCATCAC
GAPDH R TCCACCACCCTGTTGCTGTA
GAPDHZ glyceraldehyde-3-phosphate dehydrogenase.difluoride membranes (Millipore Corporation, Billerica, MA,
USA). Primary antibody for asporin (1:500 dilution; Santa
Cruz Biotechnology Inc., Paso Robles, CA, USA) and second-
ary horseradish peroxidaseeconjugated donkey antigoat
immunoglobulin G antibody (1:2000 dilution; Proteintech
Group Inc., Rosemont, IL, USA) were used. Immunoreactive
signal bands were visualised using an enhanced chem-
iluminescence kit (Thermo Fisher Scientific Inc., Waltham,
MA, USA), exposed to an X-ray film, and analysed using a
computer-assisted image analysis system (Gene Genius Bio
Imaging System, Syngene, Cambridge, UK).
Statistical analysis
All data were shown as mean  standard deviation. The
statistical analysis was performed using SPSS version 13.0
software (SPSS Inc., Chicago, IL, USA). The differences
among the groups were analysed using the one-way analysis
of variance test. A p value < 0.05 was considered statisti-
cally significant.
Results
Patients
The removed intervertebral disk tissues of eight patients
(aged 11e28 years; 2 women and 6 men), who underwent
intervertebral disk fusion surgery in the hospital after
confirmation of disease history and magnetic resonance
imaging (MRI) examination, were used in this study. One ofFigure 1 Representative magnetic resonance image of the
intervertebral disk. A 20-year-old patient with moderate to
severe intervertebral disk degeneration affecting L4e5 (Grade
IV). Sagittal magnetic resonance imaging scan (Magnetom 1.5T;
Siemens AG, Berlin, Germany) was performed with a slice
thickness of 5 mm. A T2-weighted image with a repetition of
2500 ms and an echo time of 90 ms of the intervertebral disc
was taken in all the participants.
4 X. Jiang et al.the representative MRI images of the participants is pre-
sented in Figure 1.
Induction of asporin by TGF-b1
After redifferentiation in alginate beads, the human
annulus cells were cultured in a six-well plate and treated
with 5 ng/mL, 10 ng/mL, and 15 ng/mL of TGF-b1. Using
real-time PCR, the expression of asporin was examined
every 6 hours up to 24 hours. No obvious difference was
found among different groups at the beginning of the
treatment. The asporin expression increased with the in-
duction time and the TGF-b1 concentration (Figure 2). At 24
hours after stimulation, a significant difference between
groups was observed (p < 0.003).
Knockdown of asporin by siRNA
The effect of asporin expression levels on the TGF-b1-
induced matrix biosynthesis was investigated. Transient
transfection assays were performed to knock down the
expression of asporin using siRNA. A low-cytotoxicity
transfection reagent was chosen for this experiment. The
transfection system was optimised according to the manu-
facturers’ instructions. For the liposome-based trans-
fection, the reagents had a low efficiency in some primary
cultured cells. Only a 60e70% knockdown effect was
observed at both protein and mRNA levels (Figure 3).
The effect of asporin on TGF-b1einduced matrix
biosynthesis
After confirmation of the knockdown of asporin, the cells
were incubated with 10 ng/mL of TGF-b1 for 24 hours, andFigure 2 Transforming growth factor-b1 regulates the
expression of asporin in human intervertebral annulus cells.
The human intervertebral annulus cells were cultured in a six-
well plate. When they reached confluence, culture medium
was replaced and cells were treated with transforming growth
factor-b1 at the assigned concentrations (5 ng/mL, 10 ng/mL,
and 15 ng/mL) and examined at the indicated time points (6
hours, 12 hours, 18 hours, and 24 hours). Expression of asporin
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were
quantified using real-time polymerase chain reaction. The
asporin message is normalised with GAPDH. The data are shown
as mean  standard deviation of triplicate assays.then the total mRNA from the cells was subjected to real-
time PCR to compare the difference in the expression of
ECM COL2A1 and ACAN. The results clearly showed that
TGF-b1-induced expression of COL2A1 and ACAN was
upregulated by the knockdown of asporin (Figure 4)
Verification in a Beagle dog intervertebral disk
degeneration animal model
A Beagle dog animal model using the percutaneous punc-
ture induction of intervertebral disk degeneration under x-
ray fluoroscopy was conducted, and MRI was performed to
confirm the degradation of intervertebral disks in the an-
imal model before removing the intervertebral disk tis-
sues. Western blotting was used to inspect the levels ofFigure 3 Knockdown of asporin expression by small inter-
fering RNA (siRNA). siRNA (100nM) targeting asporin or control
siRNA (NC siRNA) was transfected into cultured annulus cells.
Twenty-four hours later, the cells were treated or untreated
with 10-ng/mL transforming growth factor-b1 (TGF-b1) for
another 24 hours. (A) The knockdown efficiency was detected
using Western blotting and cell lysates were probed with
asporin antibody with glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) serving as a loading control. (B) The knock-
down efficiency was detected with real-time polymerase chain
reaction and real-time polymerase chain reaction for asporin
mRNA level normalised to that of GAPDH. The data are shown
as mean  standard deviation of triplicate assays. * p < 0.05.
Figure 4 The effect of asporin on transforming growth fac-
tor-b1 (TGF-b1)-induced matrix biosynthesis. The cultured
annulus cells were transfected with asporin siRNA or control
small interfering RNA (siRNA; 100nM). After 24 hours, the cells
were incubated with 10 ng/mL of TGF-b1 for another 24 hours.
The expression levels of (A) aggrecan and (B) type II collagen
were determined using real-time polymerase chain reaction.
The results were normalised to glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). Data are from triplicate assays.
* p < 0.05.
Figure 5 Level of asporin inside intervertebral disk in a
Beagle animal model. Percutaneous puncture induction of
intervertebral disk degeneration animal model under X-ray
fluoroscopy was conducted, and Western blotting was used to
inspect the levels of asporin inside the intervertebral disk at
the annulus regions. Tubulin was adopted as a loading control
(T13/L1: intervertebral disk between thoracic vertebrae 13
and lumbar vertebrae 1; L1/2: intervertebral disk between
lumbar vertebrae 1 and 2.) L3/4 and L6/7 were confirmed to
have lumbar disk herniation by magnetic resonance imaging.
Roles of asporin in intervertebral annulus cells 5asporin inside the intervertebral disk. In the degraded
intervertebral disks, the levels of asporin were obviously
higher compared with that from the normal ones
(Figure 5).Discussion
DDD is characterised by the abnormal intervertebral disk
structure incurred from an imbalance between catabo-
lism and anabolism and the disk cells in the disk plays a
critical role in maintaining the balance [2]. In this study,
we investigated the relationship between the expression
of asporin and TGF-b1 controlled annulus biosynthesis
process and confirmed a functional feedback loop be-
tween TGF-b1 and asporin in human intervertebral
annulus cells.
We found that the transcription of asporin increased
significantly in a dose- and time-dependent manner in
response to TGF-b1 stimulation in the disk cells from pa-
tients. This is in agreement with the results obtained in
chondrocytes [12]. Several studies suggest the overall
similarity between the chondrocytes and IVD cells in
response to many cytokines [14], and our result provides
evidence in support of this postulation.
SLRP family members, including aspirin, have the ability
to bind to TGF-b1 and inhibit the interaction of TGF-b1 with
its in vivo type II receptor [15]. However, an in vitro study
showed that such an effect had to be mediated by heparin
or heparan sulfate in the presence of type II collagen [15].
These findings suggested the existence of a regulatory
network in the ECM components for the interaction be-
tween TGF-b and its receptors. New therapeutic in-
terventions such as expression or injection of TGF-b1 into
IVD resulted in the stimulation of matrix biosynthesis
[16e18]. Our results indicate that TGF-b1-induced expres-
sion of collagen II alpha 1 and aggrecan can be significantly
enhanced by knocking down the expression of endogenous
asporin. This suggests that the inhibition of asporin could be
potentially used to improve the anabolic effect of TGF-b1
in human intervertebral annulus cells in IVD patients. It
would be intriguing to first test in animal models of IVD for
the effect of TGF-b1 in combination with the knockdown of
asporin.
In summary, this study confirmed a functional feedback
loop between TGF-b1 and asporin in human annulus cells. It
highlighted the potential use of asporin as a new preventive
or therapeutic target to enhance the anabolic effect of
TGF-b1 in degenerative IVD diseases.Conflicts of interest
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